The goal: find patterns in
the data on cancer patients to understand the disease better, and accelerate the search for new treatments.
Not exact matches
The researcher wanted him to help with a pro bono project that involved gathering
data on thousands of breast -
cancer patients.
For example, Watson for Oncology can summarize the key medical attributes of a
cancer patient and rank the best treatment options based
on the
data it has access to.
Many researchers have conducted literature reviews
on the impact of religion and spirituality
on cancer patients» health, but none have taken such thorough and painstaking efforts to analyze the
data in such detail.
To develop the nomogram, the researchers created a virtual population model representing U.S. men aged 50 to 84 years from 1975 to 2005 and applied existing
data on PSA levels, biopsy practices and
cancer diagnosis patterns to learn about
cancer progression in
patients with and without screening.
Key findings in this study show that 5 - year survival for older lung
cancer surgery
patients is favorable; surgeons will be able to better individualize care for older lung
cancer patients based
on newly and uniquely linked
data, and the prevalence of lung
cancer is expected to increase as the population continues to age.
In the current study, Zhang and her colleagues, including Esther John, Ph.D., senior
cancer epidemiologist at the Cancer Prevention Institute of California, analyzed data on 6,235 American and Canadian breast cancer patients from the Breast Cancer Family Registry, a National Cancer Institute - funded program that has collected clinical and questionnaire data on enrolled participants and their families since
cancer epidemiologist at the
Cancer Prevention Institute of California, analyzed data on 6,235 American and Canadian breast cancer patients from the Breast Cancer Family Registry, a National Cancer Institute - funded program that has collected clinical and questionnaire data on enrolled participants and their families since
Cancer Prevention Institute of California, analyzed
data on 6,235 American and Canadian breast
cancer patients from the Breast Cancer Family Registry, a National Cancer Institute - funded program that has collected clinical and questionnaire data on enrolled participants and their families since
cancer patients from the Breast
Cancer Family Registry, a National Cancer Institute - funded program that has collected clinical and questionnaire data on enrolled participants and their families since
Cancer Family Registry, a National
Cancer Institute - funded program that has collected clinical and questionnaire data on enrolled participants and their families since
Cancer Institute - funded program that has collected clinical and questionnaire
data on enrolled participants and their families since 1995.
Medical scientists,
on the other hand, are crunching billions of
data points culled from millions of
patients about genetic mutations that make people more vulnerable to diseases like diabetes, heart disease and
cancer.
An analysis of
data on 945
patients with prostate
cancer that is managed with active surveillance shows differences in outcomes depending
on whether the
patient was low or intermediate risk at diagnosis.
The study examined 328
patients with cervical
cancer and 1,312 controls, matched on age and decade, who enrolled in a hospital - based case - control study drawn from 26,831 patients who received treatment at Roswell Park Cancer Institute and completed the Patient Epidemiology Data System questionnaire between 1982 and
cancer and 1,312 controls, matched
on age and decade, who enrolled in a hospital - based case - control study drawn from 26,831
patients who received treatment at Roswell Park
Cancer Institute and completed the Patient Epidemiology Data System questionnaire between 1982 and
Cancer Institute and completed the
Patient Epidemiology
Data System questionnaire between 1982 and 1998.
Partnering with the U.S. Food and Drug Administration allowed Doebele and colleagues to access clinical trial
data describing initial tumor response, PFS and OS for 305
patients with stage IIIb or IV non-small cell lung
cancer on trials of ALK inhibitors and 355 similar
patients on trials of immunotherapies directed at PD - 1.
The Johns Hopkins team tested ImmunoMap's ability to correlate immune responses
on receptor sequencing
data from T - cells in the tumors of 34
patients with
cancer enrolled in a nationwide clinical trial of the immunotherapy drug nivolumab.
However, these studies tended to lack long - term follow - up, evaluated limited
patient numbers, had differences in medication after surgery between both groups and lacked the
data on cause of death that are needed to evaluate breast
cancer - specific survival.
The report contains
data on 3,727
patients whose samples were analyzed during the first year of the Profile program at Dana - Farber / Brigham and Women's
Cancer Center and Boston Children's Hospital.
A: Sheltzer: Professionally, we're working
on a paper together using Joan's
data - analysis ability to parse through gene - expression
data from more than 20,000
cancer patients.
They compared the results with
data from disease - free family members of the
patients as well as healthy, unrelated controls to home in
on CNVs unique to the
cancer patients.
In the new study, a Danish - Czech - U.S. team first firmed up the drug's anticancer effects by combing through Denmark's unique
cancer registry — more than 240,000 cases diagnosed between 2000 and 2013, along with
data on the medications each
patient took.
Hashimoto et al.'s
data suggest that future efforts might focus
on breast
cancer patients whose tumors express high levels of Arf6 signaling proteins, and which could therefore be susceptible to drugs that reduce the activity of Rab11b.
The NCI estimates it will take about two years to collect sufficient
data and material
on 2,400
patients across the nation with early onset of the six
cancers who are black, Hispanic, American Indian, Alaska Native or white.
Repurposing approved and abandoned drugs for
cancer represents an opportunity to rapidly advance to
patients promising drug therapies by capitalizing
on existing
data and experience.
The
data presented provide new insights
on the potential mechanism by which Seres» microbiome therapies could improve the outcomes of
cancer patients treated with immune checkpoint inhibitors.
Of the 22
patients whose tumors successfully grafted, six died before
data from the mice were available, but in 13 of the remaining 16 cases, there was a positive correlation between mouse and human results.2 In a second study, performed in collaboration with Manuel Hidalgo of the Spanish National
Cancer Research Center, the team found that 6 of 13
patients with advanced solid tumors who were treated based
on results from personalized PDX mice had partial tumor remissions, even in cases where genetic sequencing of the tumor showed no actionable mutations.3
IBM's Watson Genomics initiative, for example, is crunching
data on the entire genomes of tumors, with the hope of generating personalized medicine for
cancer patients.
Published in Science, the Atlas is based
on the analysis of 17 main
cancer types using
data from 8,000
patients.
The goal of this public
data release is to share clinical, genomic, molecular, and
patient - reported
data on metastatic breast
cancer to accelerate discoveries and the development of new treatment strategies.
We'll be back with a recap of Day 3, which promises to reveal compelling clinical
data that is certain to generate a lot of excitement among the researchers attending the conference as well as
patient advocacy groups focused
on the
cancer types that will be discussed
on Monday, April 16.
6/16/2008 UC San Diego Hyperbaric Medicine Team Contributes to War
on Cancer Leadership Role in Nationwide Study on «Late Effect» Wounds The University of California, San Diego Medical Center's Hyperbaric Medicine Center is part of a nationwide effort to compile and evaluate data in order to validate whether cancer patients... M
Cancer Leadership Role in Nationwide Study
on «Late Effect» Wounds The University of California, San Diego Medical Center's Hyperbaric Medicine Center is part of a nationwide effort to compile and evaluate
data in order to validate whether
cancer patients... M
cancer patients... More...
The scans were drawn from The
Cancer Imaging Archive, a collection of demographic, clinical and imaging data on hundreds of cancer pat
Cancer Imaging Archive, a collection of demographic, clinical and imaging
data on hundreds of
cancer pat
cancer patients.
A physicist turned computational scientist, Graber comes to the MDI Biological Laboratory from The Jackson Laboratory, also located in Bar Harbor, where he focused
on computational approaches to understanding post-transcriptional gene regulation and interactions, while also working intensively to process, analyze and interpret the genome - scale
data sets generated within the
Patient Derived Xenograft (PDX)
cancer study program.
Four of the 10 included studies presented
data on the baseline distribution of potential confounders split by quitting status.16 17 21 27 Two studies found an uneven distribution of baseline factors16 17; the group that stopped smoking contained a higher proportion of male
patients in both studies and more
patients with a history of
cancer in one study.
The work that garnered the honor, «An analysis of the risk and benefit of neoadjuvant chemotherapy among
patients undergoing surgery for non-small cell lung
cancer,» examined data from more than 134,000 patients in the National Cancer Database to assess the impact of neoadjuvant therapy on perioperative outcomes, as well as long - term sur
cancer,» examined
data from more than 134,000
patients in the National
Cancer Database to assess the impact of neoadjuvant therapy on perioperative outcomes, as well as long - term sur
Cancer Database to assess the impact of neoadjuvant therapy
on perioperative outcomes, as well as long - term survival.
Newly published
data on patients with prostate
cancer suggest, however, that being given the diagnosis may, in itself, be associated with a marked increase in the risk of stress - related disease and death.
Life table modelling
on the basis of these
data estimated 33 % five year survival in 65 year old
patients with early stage non-small cell lung
cancer who continued to smoke compared with 70 % in those who quit smoking.
Endpoints News Editor John Carroll will review some startling new
data on the
cancer pipeline and lead a discussion
on how this revolution can best be managed — to the advantage of
patients, physicians and the biopharma companies leading the boom.
Cancer Research UK's scientists are investigating new ways to treat
patients in a more targeted way based
on their genetic fingerprint — but this research produces terabytes upon petabytes of
data requiring analysis.
The
data reported were based
on one
patient and, despite 67 years of subsequent studies that failed to establish scientific support for this theory, we are still faced with reluctance to treat men with testosterone supplementation for fear of giving them prostate
cancer or fueling prostate
cancer already present at a subclinical or microscopic level.
The NantOmics
Cancer Genome Browser platform
on the BlackBerry Passport enables deep, interactive reporting
on genomics
data for physicians and other treatment providers in clinical settings — for example, giving oncologists a powerful view into the individual genetic alternations that make each
patient's disease unique and highlighting relevant treatment options.
The FDA Warns
Patients Based on the five - year data, the FDA officially recommends that patients who are already suffering from bladder cancer should not us
Patients Based
on the five - year
data, the FDA officially recommends that
patients who are already suffering from bladder cancer should not us
patients who are already suffering from bladder
cancer should not use Actos.
Maintained
cancer patient program, ensuring accuracy
on data entry and tracking of 300 +
cancer patients and their follow - up schedules.
The second talk (Tolgou et al.) will then present
data on imagery rescripting in
cancer patients with depression, and will link these findings to clinical practice.